Optimizing Quality of Life in Women Living With Metastatic Breast Cancer

STATUS

Recruiting
participants needed

30
sponsor

Northwestern University

Send

Updated on 19 February 2024

See if I qualify

cancer

breast cancer

acceptance and commitment therapy

stage iv breast cancer

female breast cancer

Summary

The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and what kinds of support women would like to receive in a tailored Acceptance and Commitment Therapy (ACT) intervention. In the second phase of the study, we will conduct a three-arm randomized controlled trial to the tailored ACT intervention with both a Cognitive Behavioral Stress Management (CBSM) intervention and usual care. The CBSM and ACT intervention groups will meet with a trained facilitator and 8-9 other patients, once per week via videoconference for 90 minute sessions over the course of 8 weeks.

Details

Condition	Metastatic Breast Cancer
Age	18years - 100years
Treatment	Acceptance and Commitment Therapy (ACT), Cognitive Behavioral Stress Management (CBSM)
Clinical Study Identifier	NCT04374825
Sponsor	Northwestern University
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Patients must be diagnosed with metastatic (stage IV [M1]) female breast cancer, via physician diagnosis and confirmed through staff review of electronic medical record (i.e. imaging, surgical pathology reports, etc.)
	Patients must be comfortable speaking English for participation in group sessions
	Patients must be age 18 years
	Patients taking part in the 8 week online pilot trial must have a physician-anticipated life expectancy of > 6 months
	Patients must have the ability to understand, and the willingness to sign, a written informed consent prior to registration on study
Exclusion Criteria
	Patients who have severe or impairing psychiatric illness/social situations that would limit compliance with study requirements are not eligible to enroll
	Patients with early stage/non metastatic breast cancer (Stages I-III) are not eligible to enroll

How to participate?

Step 1 Connect with a study center

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer

breast cancer

acceptance and commitment therapy

stage iv breast cancer

female breast cancer

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Optimizing Quality of Life in Women Living With Metastatic Breast Cancer